Effects of a Western-type Diet on Colorectal Inflammation
Primary Purpose
Colorectal Inflammation
Status
Completed
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
Western style diet (high fat and low in calcium)
Prudent-style diet (low fat and high in calcium)
Sponsored by

About this trial
This is an interventional basic science trial for Colorectal Inflammation
Eligibility Criteria
Inclusion Criteria:
- Healthy male or post-menopausal ( 2 years after menopause or stopping HRT)healthy female subjects
- Age between 50 and 72 years
- At increased risk for colorectal cancer (this includes those have had a colorectal adenoma excised, or have a first or second degree relative with colorectal neoplasia).
Exclusion Criteria:
- Personal history of cancer other than non-melanoma skin cancer within the past 10 years
- History of hereditary non-polyposis colon cancer
- Intestinal malabsorption, inflammatory bowel disease
- Prior gastrointestinal surgery other than appendectomy or surgery of the esophagus
- Any excess bleeding or coagulation disorders
- Subjects taking anti-coagulants, sterol-binding resins, NSAIDs other than aspirin, < 600mg per day, other study medications, or other multiple medications that might, in the view of the study physicians, alter colonic function or inflammation
- Total cholesterol greater than 240mg/dl, triglycerides > 600mg, LDL-C > 175
- Subjects with a history of coronary artery disease
- HIV positive subjects
- Subjects taking antibiotics, anti-diabetes, hormone replacement therapy, oral, transplanted or injected contraceptives (thyroid hormone therapy is permitted as long as the subject is euthyroid)
- Currently participating in other clinical studies or completed participation in other clinical studies within the last 30 days
Sites / Locations
- Rockefeller University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Western style diet
Prudent diet
Arm Description
high-fat, low-calcium diet
low-fat, calcium-sufficient diet
Outcomes
Primary Outcome Measures
Inflammation in the rectosigmoid epithelium
Secondary Outcome Measures
Circulating endotoxin levels
Expression profiles of pro- and anti-inflammatory genes in rectosigmoid biopsies
Gut permeability
Inflammatory cytokines in the colorectal mucosa and serum
Luminal and adherent gut microbiota
Fecal calprotectin levels in the stool samples
Full Information
NCT ID
NCT00866450
First Posted
March 19, 2009
Last Updated
January 10, 2012
Sponsor
Rockefeller University
1. Study Identification
Unique Protocol Identification Number
NCT00866450
Brief Title
Effects of a Western-type Diet on Colorectal Inflammation
Official Title
Effects of a Western-type Diet on Colorectal Inflammation, Gut Permeability and Systemic Endotoxemia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2012
Overall Recruitment Status
Completed
Study Start Date
February 2009 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
February 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rockefeller University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will look at the inflammatory (changes usually associated with infection/injury to the body) and bowel permeability (bowel's ability to allow contents to enter the body) effects of a Western-style diet (high fat and low in calcium) and a prudent-style diet (low fat and high in calcium) on the colon (large bowel). This study may provide information to prevent colorectal cancer in a high-risk population
Detailed Description
Hypothesis: Compared to a prudent-style diet, does a western-style diet increase colorectal inflammation thereby increasing gut permeability and causing increased endotoxins and markers of systemic inflammation.
This is a single blind crossover study. Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days. The following study measures are performed during both the dietary intervention study periods. All the baseline tests will be repeated at the end of each dietary intervention period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Inflammation
7. Study Design
Primary Purpose
Basic Science
Study Phase
Early Phase 1
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Western style diet
Arm Type
Active Comparator
Arm Description
high-fat, low-calcium diet
Arm Title
Prudent diet
Arm Type
Active Comparator
Arm Description
low-fat, calcium-sufficient diet
Intervention Type
Dietary Supplement
Intervention Name(s)
Western style diet (high fat and low in calcium)
Intervention Description
Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days
Intervention Type
Dietary Supplement
Intervention Name(s)
Prudent-style diet (low fat and high in calcium)
Intervention Description
Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days
Primary Outcome Measure Information:
Title
Inflammation in the rectosigmoid epithelium
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Secondary Outcome Measure Information:
Title
Circulating endotoxin levels
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Title
Expression profiles of pro- and anti-inflammatory genes in rectosigmoid biopsies
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Title
Gut permeability
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Title
Inflammatory cytokines in the colorectal mucosa and serum
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Title
Luminal and adherent gut microbiota
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Title
Fecal calprotectin levels in the stool samples
Time Frame
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
72 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Healthy male or post-menopausal ( 2 years after menopause or stopping HRT)healthy female subjects
Age between 50 and 72 years
At increased risk for colorectal cancer (this includes those have had a colorectal adenoma excised, or have a first or second degree relative with colorectal neoplasia).
Exclusion Criteria:
Personal history of cancer other than non-melanoma skin cancer within the past 10 years
History of hereditary non-polyposis colon cancer
Intestinal malabsorption, inflammatory bowel disease
Prior gastrointestinal surgery other than appendectomy or surgery of the esophagus
Any excess bleeding or coagulation disorders
Subjects taking anti-coagulants, sterol-binding resins, NSAIDs other than aspirin, < 600mg per day, other study medications, or other multiple medications that might, in the view of the study physicians, alter colonic function or inflammation
Total cholesterol greater than 240mg/dl, triglycerides > 600mg, LDL-C > 175
Subjects with a history of coronary artery disease
HIV positive subjects
Subjects taking antibiotics, anti-diabetes, hormone replacement therapy, oral, transplanted or injected contraceptives (thyroid hormone therapy is permitted as long as the subject is euthyroid)
Currently participating in other clinical studies or completed participation in other clinical studies within the last 30 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Swaroop Pendyala, MD
Organizational Affiliation
Rockefeller University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rockefeller University
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effects of a Western-type Diet on Colorectal Inflammation
We'll reach out to this number within 24 hrs